STELIOS PAPADOPOULOS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STELIOS PAPADOPOULOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STELIOS PAPADOPOULOS. STELIOS PAPADOPOULOS is a Director in BIOGEN INC. ($IDPH) and a Director in EXELIXIS, INC. ($EXEL) and a Director in BG Medicine, Inc. ($BGMD) and a Director in Regulus Therapeutics Inc. ($RGLS) and a Director in Eucrates Biomedical Acquisition Corp. ($EUCR).
Companies in which STELIOS PAPADOPOULOS is an Insider
BG Medicine, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of STELIOS PAPADOPOULOS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 20 2015
$BGMD Market Capitalization: $871563.00
$BGMD Previous Close: $0.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STELIOS PAPADOPOULOS: Director
Holdings: 6,565 shares
Latest Transaction: Jun 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eucrates Biomedical Acquisition Corp.
Industry: BLANK CHECKS [6770]
Position of STELIOS PAPADOPOULOS: Director
Holdings: 2,619,906 shares
Latest Transaction: Nov 27 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EXELIXIS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STELIOS PAPADOPOULOS: Director
Holdings: 1,228,897 shares
Current Value: $25,278,411
Latest Transaction: May 13 2021
$EXEL Market Capitalization: $6.19B
$EXEL Previous Close: $20.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STELIOS PAPADOPOULOS: Director
Holdings: 1,986,729 shares
Current Value: $2,781,421
Latest Transaction: Dec 07 2020
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of STELIOS PAPADOPOULOS
Sentiment: All, BGMD, IDPH, EUCRW, EXEL, RGLS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 3.13 | 40,000 | 125,200 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 6.30 | 40,000 | 252,000 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.01 | 5,473 | 136,880 | 1,288,127 | 1.3 M to 1.3 M (-0.42 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 3.38 | 40,000 | 135,200 | 1,293,600 | 1.3 M to 1.3 M (+3.19 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.00 | 5,075 | 126,875 | 1,253,600 | 1.3 M to 1.3 M (-0.40 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 3.13 | 40,000 | 125,200 | 1,258,675 | 1.2 M to 1.3 M (+3.28 %) |